Ticker: BBIO

Company: BridgeBio Pharma, Inc.

Person: Neil Kumar, director, officer

Transaction date: May 7, 2026

Reporting date: May 11, 2026

Average share price: 67.40304268375

Sold 80000.0 shares for 5392243.41